Anti-ADH1A/ ADH1 monoclonal antibody

Anti-ADH1A/ ADH1 antibody for FACS & in-vivo assay

Target products collectionGo to ADH1A/ADH1A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T65570-Ab-1/ GM-Tg-hg-T65570-Ab-2Anti-Human ADH1A monoclonal antibodyHuman
GM-Tg-rg-T65570-Ab-1/ GM-Tg-rg-T65570-Ab-2Anti-Rat ADH1A monoclonal antibodyRat
GM-Tg-mg-T65570-Ab-1/ GM-Tg-mg-T65570-Ab-2Anti-Mouse ADH1A monoclonal antibodyMouse
GM-Tg-cynog-T65570-Ab-1/ GM-Tg-cynog-T65570-Ab-2Anti-Cynomolgus/ Rhesus macaque ADH1A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T65570-Ab-1/ GM-Tg-felg-T65570-Ab-2Anti-Feline ADH1A monoclonal antibodyFeline
GM-Tg-cang-T65570-Ab-1/ GM-Tg-cang-T65570-Ab-2Anti-Canine ADH1A monoclonal antibodyCanine
GM-Tg-bovg-T65570-Ab-1/ GM-Tg-bovg-T65570-Ab-2Anti-Bovine ADH1A monoclonal antibodyBovine
GM-Tg-equg-T65570-Ab-1/ GM-Tg-equg-T65570-Ab-2Anti-Equine ADH1A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T65570-Ab-1/ GM-Tg-hg-T65570-Ab-2; GM-Tg-rg-T65570-Ab-1/ GM-Tg-rg-T65570-Ab-2;
GM-Tg-mg-T65570-Ab-1/ GM-Tg-mg-T65570-Ab-2; GM-Tg-cynog-T65570-Ab-1/ GM-Tg-cynog-T65570-Ab-2;
GM-Tg-felg-T65570-Ab-1/ GM-Tg-felg-T65570-Ab-2; GM-Tg-cang-T65570-Ab-1/ GM-Tg-cang-T65570-Ab-2;
GM-Tg-bovg-T65570-Ab-1/ GM-Tg-bovg-T65570-Ab-2; GM-Tg-equg-T65570-Ab-1/ GM-Tg-equg-T65570-Ab-2
Products NameAnti-ADH1A monoclonal antibody
Formatmab
Target NameADH1A
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ADH1A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ADH1A/ ADH1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP002303human ADH1A Lentivirus plasmid
    ORF Viral VectorvGMLP002303human ADH1A Lentivirus particle


    Target information

    Target IDGM-T65570
    Target NameADH1A
    Gene ID124
    Gene Symbol and SynonymsADH1,ADH1A
    Uniprot AccessionP07327
    Uniprot Entry NameADH1A_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000187758
    Target ClassificationN/A

    The target: ADH1A, gene name: ADH1A, also named as ADH1. This gene encodes a member of the alcohol dehydrogenase family. The encoded protein is the alpha subunit of class I alcohol dehydrogenase, which consists of several homo- and heterodimers of alpha, beta and gamma subunits. Alcohol dehydrogenases catalyze the oxidation of alcohols to aldehydes. This gene is active in the liver in early fetal life but only weakly active in adult liver. This gene is found in a cluster with six additional alcohol dehydrogenase genes, including those encoding the beta and gamma subunits, on the long arm of chromosome 4. Mutations in this gene may contribute to variation in certain personality traits and substance dependence. [provided by RefSeq, Nov 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.